167 related articles for article (PubMed ID: 23237280)
21. Rearranged T-cell receptor gene and positive Epstein-Barr virus-encoded nuclear RNA in an extranodal NK/T-cell lymphoma with cutaneous manifestation only: case study.
Wang J; Geng SA; Su Z; Xu J; Xu S; Wang F; Mo X; Feng Z
Clin Exp Dermatol; 2007 Nov; 32(6):744-8. PubMed ID: 17953643
[TBL] [Abstract][Full Text] [Related]
22. Primary cutaneous aggressive epidermotropic CD8(+) cytotoxic T-cell lymphoma with atypical presentation.
Kim SK; Kim YC; Kang HY
J Dermatol; 2006 Sep; 33(9):632-4. PubMed ID: 16958809
[TBL] [Abstract][Full Text] [Related]
23. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma.
Gormley RH; Hess SD; Anand D; Junkins-Hopkins J; Rook AH; Kim EJ
J Am Acad Dermatol; 2010 Feb; 62(2):300-7. PubMed ID: 19944484
[TBL] [Abstract][Full Text] [Related]
24. Acneiform primary cutaneous CD4-positive small/medium pleomorphic T-cell lymphoma with prominent necrosis.
Wang L; Wang G; Gao T
J Cutan Pathol; 2015 Apr; 42(4):265-70. PubMed ID: 25407448
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous peripheral T-cell lymphomas, unspecified/NOS and rare subtypes: a heterogeneous group of challenging cutaneous lymphomas.
Kempf W; Rozati S; Kerl K; French LE; Dummer R
G Ital Dermatol Venereol; 2012 Dec; 147(6):553-62. PubMed ID: 23149701
[TBL] [Abstract][Full Text] [Related]
26. Non-mycosis fungoides cutaneous T-cell lymphoma: reclassification according to the WHO-EORTC classification.
Weaver J; Mahindra AK; Pohlman B; Jin T; Hsi ED
J Cutan Pathol; 2010 May; 37(5):516-24. PubMed ID: 20132421
[TBL] [Abstract][Full Text] [Related]
27. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: transformation from indolent to aggressive phase in association with CCR7-positive conversion.
Kasuya A; Hirakawa S; Tokura Y
Dermatol Online J; 2012 Oct; 18(10):5. PubMed ID: 23122012
[TBL] [Abstract][Full Text] [Related]
28. A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases.
Saggini A; Gulia A; Argenyi Z; Fink-Puches R; Lissia A; Magaña M; Requena L; Simonitsch I; Cerroni L
Am J Surg Pathol; 2010 Aug; 34(8):1168-75. PubMed ID: 20661014
[TBL] [Abstract][Full Text] [Related]
29. Primary cutaneous γδ T-cell lymphoma with unusual immunophenotype: A case report and review of published work.
Kamijo H; Miyagaki T; Norimatsu Y; Awaji K; Oka T; Suga H; Sugaya M; Sato S
J Dermatol; 2020 Mar; 47(3):300-305. PubMed ID: 31912565
[TBL] [Abstract][Full Text] [Related]
30. Pleomorphic CD8+ small/medium size cutaneous T-cell lymphoma.
Khamaysi Z; Ben-Arieh Y; Epelbaum R; Bergman R
Am J Dermatopathol; 2006 Oct; 28(5):434-7. PubMed ID: 17012921
[TBL] [Abstract][Full Text] [Related]
31. Primary cutaneous γδ-T-cell lymphoma treated with low-dose methotrexate and narrowband ultraviolet B irradiation: report of a case with testicular involvement.
Fujii M; Uehara J; Honma M; Ito Y; Takahashi H; Ishida-Yamamoto A; Iizuka H
J Dermatol; 2011 Apr; 38(4):368-72. PubMed ID: 21352347
[TBL] [Abstract][Full Text] [Related]
32. Primary cutaneous aggressive epidermotropic CD8+ T cell lymphoma with a chronic and indolent course. Is this different from peripheral T cell lymphoma?
Gomez Vazquez M; Navarra Amayuelas R
Dermatol Online J; 2012 Mar; 18(3):11. PubMed ID: 22483522
[TBL] [Abstract][Full Text] [Related]
33. Diffuse large cell non-Hodgkin's lymphoma, CD30+, T-cell phenotype.
Gruson LM; Latkowski JA
Dermatol Online J; 2005 Dec; 11(4):17. PubMed ID: 16403389
[TBL] [Abstract][Full Text] [Related]
34. [Unusual course of CD8+ epidermotropic cutaneous T-cell lymphoma].
Gardette E; Moguelet P; Barete S; Frances C; Senet P
Ann Dermatol Venereol; 2016 Dec; 143(12):846-851. PubMed ID: 27161647
[TBL] [Abstract][Full Text] [Related]
35. The protean spectrum of non-Hodgkin lymphomas with prominent involvement of subcutaneous fat.
Massone C; Lozzi GP; Egberts F; Fink-Puches R; Cota C; Kerl H; Cerroni L
J Cutan Pathol; 2006 Jun; 33(6):418-25. PubMed ID: 16776717
[TBL] [Abstract][Full Text] [Related]
36. Epidermotropic CD8+ cytotoxic T-cell lymphoma exhibiting a transition from the indolent to the aggressive phase, accompanied by emergence of CD7+ cells and formation of neutrophilic pustules.
Ito Y; Goto M; Hatano Y; Kawamoto M; Ohishi M; Takayasu S; Katagiri K; Fujiwara S
Clin Exp Dermatol; 2012 Mar; 37(2):128-31. PubMed ID: 21883402
[TBL] [Abstract][Full Text] [Related]
37. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma with a CD15(+)CD30(-) phenotype.
Yoshizawa N; Yagi H; Horibe T; Takigawa M; Sugiura M
Eur J Dermatol; 2007; 17(5):441-2. PubMed ID: 17673391
[TBL] [Abstract][Full Text] [Related]
38. Cutaneous T-cell lymphoma occurring with a melanocytic proliferation, masquerading as a nonhealing ulcer with reactive changes.
Kanner WA; White KP; Barry CI; Lee AJ; Cousar JB; Wick MR; Patterson JW
J Cutan Pathol; 2011 Jan; 38(1):67-72. PubMed ID: 20002651
[TBL] [Abstract][Full Text] [Related]
39. Lymphomatoid papulosis type D: a newly described variant easily confused with cutaneous aggressive CD8-positive cytotoxic T-cell lymphoma.
Cardoso J; Duhra P; Thway Y; Calonje E
Am J Dermatopathol; 2012 Oct; 34(7):762-5. PubMed ID: 22688398
[TBL] [Abstract][Full Text] [Related]
40. Primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoma: temporary remission by oral doxycycline.
Toberer F; Hartschuh W; Hadaschik E
JAMA Dermatol; 2013 Aug; 149(8):956-9. PubMed ID: 23760549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
